Vertex Pharmaceuticals Incorporated VRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

84/100

5/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Vertex Pharmaceuticals Incorporated (VRTX), dont 1 achat et 48 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $50.44M.

Les initiés notables ayant une activité récente comprennent Liu Joy, Bozic Carmen, Mckechnie Duncan. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — VRTX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Liu Joy	EVP and Chief Legal Officer	Vente Informative	978	$449.17	$439.29K	21,833
2026-03-27	Bozic Carmen	EVP and CMO	Vente Informative	2,329	$450.95	$1.05M	33,076
2026-03-13	Bozic Carmen	EVP and CMO	Vente Informative	2,329	$481.79	$1.12M	35,405
2026-03-11	Mckechnie Duncan	EVP, Chief Commercial Officer	Vente Informative	2,633	$498.42	$1.31M	12,489
2026-03-04	Mckechnie Duncan	EVP, Chief Commercial Officer	Vente Informative	2,437	$475.30	$1.16M	15,122
2026-03-02	Liu Joy	EVP and Chief Legal Officer	Vente Informative	892	$495.96	$442.4K	22,811
2026-03-01	Liu Joy	EVP and Chief Legal Officer	Inconnu	7,044	$155.57	$1.1M	-
2026-02-27	Kewalramani Reshma	CEO & President	Vente Informative	1,725	$496.95	$857.24K	98,278
2026-02-27	Bozic Carmen	EVP and CMO	Vente Informative	2,329	$480.31	$1.12M	37,734
2026-02-26	Ambrose Kristen	SVP & Chief Accounting Officer	Vente Informative	357	$483.36	$172.56K	6,624
2026-02-25	Sachdev Amit	EVP Chief Patient & Ext Af Off	Vente Informative	1,846	$486.35	$897.8K	55,570
2026-02-25	Biller Jonathan	EVP and Chief Legal Officer	Vente Informative	945	$486.35	$459.6K	13,659
2026-02-25	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Vente Informative	260	$486.35	$126.45K	46,763
2026-02-25	Ambrose Kristen	SVP & Chief Accounting Officer	Vente Informative	223	$486.35	$108.46K	6,981
2026-02-25	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Vente Informative	668	$486.35	$324.88K	18,432
2026-02-25	Mckechnie Duncan	EVP, Chief Commercial Officer	Vente Informative	2,410	$489.00	$1.18M	17,559
2026-02-25	Bunnage Mark E.	EVP, Chief Scientific Officer	Vente Informative	620	$486.35	$301.54K	7,284
2026-02-24	Wagner Charles F Jr	EVP, Co & Fo	Retenue Fiscale RSU	1,744	$485.11	$846.03K	47,042
2026-02-24	Leiden Jeffrey M	Executive Chairman	Retenue Fiscale RSU	3,547	$485.11	$1.72M	34,797
2026-02-24	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retenue Fiscale RSU	1,518	$485.11	$736.4K	57,416
2026-02-24	Kewalramani Reshma	CEO & President	Retenue Fiscale RSU	4,981	$485.11	$2.42M	138,278
2026-02-24	Biller Jonathan	EVP and Chief Legal Officer	Retenue Fiscale RSU	1,144	$485.11	$554.97K	14,604
2026-02-24	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Retenue Fiscale RSU	1,627	$485.11	$789.27K	47,023
2026-02-24	Bozic Carmen	EVP and CMO	Retenue Fiscale RSU	1,453	$485.11	$704.86K	40,063
2026-02-24	Ambrose Kristen	SVP & Chief Accounting Officer	Retenue Fiscale RSU	546	$485.11	$264.87K	7,204
2026-02-24	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Retenue Fiscale RSU	1,627	$485.11	$789.27K	19,100
2026-02-24	Mckechnie Duncan	EVP, Chief Commercial Officer	Retenue Fiscale RSU	873	$485.11	$423.5K	22,469
2026-02-24	Bunnage Mark E.	EVP, Chief Scientific Officer	Retenue Fiscale RSU	582	$485.11	$282.33K	7,904
2026-02-19	Sachdev Amit	EVP Chief Patient & Ext Af Off	Exercice d'Options (Vente)	25,026	$187.53	$4.69M	-
2026-02-18	Leiden Jeffrey M	Executive Chairman	Retenue Fiscale RSU	2,964	$483.75	$1.43M	38,344
2026-02-18	Biller Jonathan	EVP and Chief Legal Officer	Vente Informative	1,244	$473.68	$589.26K	15,748
2026-02-18	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Vente Informative	368	$473.68	$174.31K	48,650
2026-02-18	Ambrose Kristen	SVP & Chief Accounting Officer	Vente Informative	638	$473.68	$302.21K	7,750
2026-02-18	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Vente Informative	817	$473.68	$387K	20,727
2026-02-18	Bunnage Mark E.	EVP, Chief Scientific Officer	Vente Informative	1,182	$473.68	$559.89K	8,486
2026-02-17	Wagner Charles F Jr	EVP, Co & Fo	Retenue Fiscale RSU	2,294	$483.75	$1.11M	48,786
2026-02-17	Leiden Jeffrey M	Executive Chairman	Attribution de RSU	8,269	-	-	41,308
2026-02-17	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retenue Fiscale RSU	2,140	$483.75	$1.04M	69,042
2026-02-17	Kewalramani Reshma	CEO & President	Retenue Fiscale RSU	6,554	$483.75	$3.17M	143,259
2026-02-17	Biller Jonathan	EVP and Chief Legal Officer	Vente Informative	2,476	$489.46	$1.21M	16,992
2026-02-17	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Vente Informative	609	$489.46	$298.08K	49,018
2026-02-17	Bozic Carmen	EVP and CMO	Retenue Fiscale RSU	1,912	$483.75	$924.93K	41,516
2026-02-17	Ambrose Kristen	SVP & Chief Accounting Officer	Vente Informative	1,557	$489.46	$762.09K	8,388
2026-02-17	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Vente Informative	2,031	$489.46	$994.09K	21,544
2026-02-17	Mckechnie Duncan	EVP, Chief Commercial Officer	Retenue Fiscale RSU	1,148	$483.75	$555.35K	23,342
2026-02-17	Bunnage Mark E.	EVP, Chief Scientific Officer	Vente Informative	2,437	$489.46	$1.19M	9,668
2026-02-13	Wagner Charles F Jr	EVP, Co & Fo	Retenue Fiscale RSU	4,565	$487.76	$2.23M	43,715
2026-02-13	Sachdev Amit	EVP Chief Patient & Ext Af Off	Retenue Fiscale RSU	3,548	$487.76	$1.73M	65,393
2026-02-13	Bhatia Sangeeta N.	Director	Vente Informative	266	$500.00	$133K	4,299
2026-02-13	Kewalramani Reshma	CEO & President	Retenue Fiscale RSU	13,041	$487.76	$6.36M	133,487

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration